Peel Hunt Reiterates “Buy” Rating for Clinigen Group PLC (CLIN)

Peel Hunt restated their buy rating on shares of Clinigen Group PLC (LON:CLIN) in a report published on Wednesday. The firm currently has a GBX 1,015 ($12.54) price objective on the stock.

Other analysts have also recently issued research reports about the stock. Numis Securities Ltd reissued a buy rating and set a GBX 933 ($11.52) target price on shares of Clinigen Group PLC in a research note on Wednesday, January 25th. N+1 Singer boosted their target price on shares of Clinigen Group PLC from GBX 800 ($9.88) to GBX 895 ($11.05) and gave the stock a buy rating in a research note on Wednesday, January 25th. Finally, Stifel Nicolaus boosted their target price on shares of Clinigen Group PLC from GBX 800 ($9.88) to GBX 900 ($11.12) and gave the stock a buy rating in a research note on Wednesday, January 25th.

Shares of Clinigen Group PLC (LON:CLIN) opened at 783.00 on Wednesday. The stock’s market cap is GBX 897.31 million. The firm has a 50-day moving average price of GBX 830.06 and a 200-day moving average price of GBX 758.66. Clinigen Group PLC has a 52 week low of GBX 492.75 and a 52 week high of GBX 875.30.

Your IP Address:

The firm also recently disclosed a dividend, which will be paid on Thursday, April 13th. Investors of record on Thursday, March 23rd will be paid a dividend of GBX 1.60 ($0.02) per share. The ex-dividend date of this dividend is Thursday, March 23rd. This represents a yield of 0.2%.

Clinigen Group PLC Company Profile

This story was originally published by WKRB News (http://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://www.wkrb13.com/markets/2024489/peel-hunt-reiterates-buy-rating-for-clinigen-group-plc-clin.html

Receive News & Ratings for Clinigen Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clinigen Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.

 


Leave a Reply

 
© 2006-2017 WKRB News.